Encore Medical, L.P.

Encore Medical, L.P. Surgical Implant Division, doing business as Empi Inc., manufactures and supplies orthopedic surgical implants and prosthetic devices to the Department of Veterans Affairs as a large-business prime contractor, operating exclusively in full-and-open competition with no set-aside designations. The company is a subsidiary of Colfax Corporation, headquartered in Austin, Texas, and competes across 757 prime awards spanning the past five years with combined potential value of $54.9 million, of which $9.8 million has been obligated.

Encore Medical's federal portfolio concentrates almost entirely on VA procurement. The Department of Veterans Affairs accounts for 94% of combined potential value across all awards. Within the VA, the concentration is acute: VA Headquarters drives $44.5 million (81% of total portfolio value) through a single master indefinite-delivery contract, while the regional Veterans Integrated Service Networks account for the remaining awards in smaller dollar increments. Veterans Integrated Service Network 8 leads by award count with 270 orders totaling $2.8 million potential value, followed by VISN 10 with 115 awards and $1.7 million. The company also serves the Army Medical Command with 17 awards totaling $859 thousand. This concentration reflects Encore Medical's positioning as a specialized orthopedic implant vendor locked into VA supply relationships rather than a diversified medical device supplier.

Encore Medical's primary capability centers on shoulder, hip, and knee arthroplasty components, reverse shoulder arthroplasty devices, total shoulder and hip replacement implants, knee revision implants, prosthetic devices, post-operative surgical supplies, and specialized bone screws. A representative $1.7 million purchase order from VISN 22 awarded in May 2024 procured percutaneous osseointegrated prosthesis (POP) devices and surgical instrumentation to support a VA cooperative clinical study. Smaller orders dominate the portfolio: individual delivery orders and purchase orders typically range from $10,000 to $50,000, with shoulder implants, hip replacements, and knee arthroplasties as the recurring line items across multiple VA regional networks.

Encore Medical holds the single-award Indefinite Delivery Contract titled "Surgical Implant Next Generation" (VA797P0264), awarded by VA Headquarters on September 30, 2023, with an $11.7 million ceiling through September 29, 2028. This vehicle has generated 123 task orders totaling $811 thousand in combined potential value, with performance spanning Veterans Integrated Service Networks 1, 2, 10, 16, 17, 19, 21, 22, and 23 nationwide and administrative oversight in Austin, Texas. Encore Medical also operates under the legacy VA Prosthetic Implants and Appliances 2016-2021 master IDIQ, which has issued 240 task orders totaling $3.2 million potential value. A third vehicle, Indefinite Delivery Contract 36C10G23D0058, carries 40 task orders worth $522 thousand. All awards are firm-fixed-price with no set-aside designations.

Activity has grown modestly year over year — from 4 awards in 2022 to 27 in 2024, declining to 20 awarded through September 2026 — and the recompete exposure is minimal. Only 14 awards with combined potential value of $344 thousand face ultimate completion within the next twenty-four months, limiting near-term recompete risk for competitors. Encore Medical competes solely as a prime contractor; it does not appear in the source as a subcontractor to other federal vendors.